Government Sets Price Caps on 30 Essential Medicines Including Vitamin D3
MRPs Set for 30 Medicines Including Vitamin D3 and Methylcobalamin

Image: Pratidin Tv - Breaking News & Latest Update
The National Pharmaceutical Pricing Authority (NPPA) has established Maximum Retail Prices (MRPs) for 30 essential medicines, including Vitamin D3 and Methylcobalamin, effective immediately. This initiative aims to enhance affordability and transparency in the pharmaceutical market.
- 01The NPPA announced the MRP for 30 medicines on May 27, 2026, effective immediately.
- 02The price of Vitamin D3, Calcium, Methylcobalamin, Pyridoxal-5 Phosphate, and L-Methylfolate Calcium is set at ₹19.78 per tablet.
- 03Atorvastatin and Fenofibrate Tablets, used for cholesterol management, are priced at ₹18.46 per tablet.
- 04The pricing initiative aims to protect consumers from excessive price fluctuations.
- 05Manufacturers must adhere to these approved rates, ensuring fair access to essential medicines.
Advertisement
In-Article Ad
To enhance the affordability of essential medicines, the National Pharmaceutical Pricing Authority (NPPA) has fixed the Maximum Retail Prices (MRPs) for 30 drug formulations. This decision, announced on May 27, 2026, aims to ensure that commonly used medications remain accessible to the public. Among the medicines affected are Vitamin D3 Oral Solution, Calcium, Methylcobalamin, and various heart-related medications. The NPPA has set the retail price for a tablet containing Vitamin D3, Calcium, Methylcobalamin, Pyridoxal-5 Phosphate, and L-Methylfolate Calcium at ₹19.78. Additionally, Atorvastatin and Fenofibrate Tablets, which are essential for cholesterol management, will now cost ₹18.46 per tablet. The NPPA emphasizes that these price caps will protect consumers from unreasonable price variations and promote transparency in the pharmaceutical market. Manufacturers and marketing companies are mandated to sell these medicines at the established rates, providing patients with relief through fair pricing across the country.
Advertisement
In-Article Ad
The price caps on essential medicines are expected to ease the financial burden on patients, making healthcare more accessible.
Advertisement
In-Article Ad
Reader Poll
How do you feel about the new price caps on essential medicines?
Connecting to poll...
More about National Pharmaceutical Pricing Authority
Read the original article
Visit the source for the complete story.




